Masimo Past Earnings Performance
Past criteria checks 1/6
Masimo's earnings have been declining at an average annual rate of -10.9%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 21.2% per year. Masimo's return on equity is 6%, and it has net margins of 4%.
Key information
-10.9%
Earnings growth rate
-11.2%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 21.2% |
Return on equity | 6.0% |
Net Margin | 4.0% |
Last Earnings Update | 30 Dec 2023 |
Recent past performance updates
Recent updates
Masimo Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 29Estimating The Intrinsic Value Of Masimo Corporation (NASDAQ:MASI)
Feb 24Masimo: Given The Lack Of Improvement In Revenues And Margins, It Is A Little Expensive
Feb 18These 4 Measures Indicate That Masimo (NASDAQ:MASI) Is Using Debt Extensively
Feb 08Earnings Tell The Story For Masimo Corporation (NASDAQ:MASI) As Its Stock Soars 27%
Dec 23At US$112, Is It Time To Put Masimo Corporation (NASDAQ:MASI) On Your Watch List?
Dec 14Masimo Corporation (NASDAQ:MASI) Shares Could Be 38% Below Their Intrinsic Value Estimate
Nov 09Is Masimo (NASDAQ:MASI) Using Too Much Debt?
Sep 19Is There Now An Opportunity In Masimo Corporation (NASDAQ:MASI)?
Aug 04Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden
Jun 20Is It Too Late To Consider Buying Masimo Corporation (NASDAQ:MASI)?
May 05Masimo (NASDAQ:MASI) Seems To Use Debt Quite Sensibly
Mar 22When Should You Buy Masimo Corporation (NASDAQ:MASI)?
Feb 02Does Masimo (NASDAQ:MASI) Have A Healthy Balance Sheet?
Dec 22Is Masimo Corporation (NASDAQ:MASI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 02Should You Think About Buying Masimo Corporation (NASDAQ:MASI) Now?
Sep 16We Think Masimo (NASDAQ:MASI) Can Stay On Top Of Its Debt
Aug 17Revenue & Expenses BreakdownBeta
How Masimo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Dec 23 | 2,048 | 82 | 682 | 175 |
30 Sep 23 | 2,116 | 89 | 700 | 192 |
01 Jul 23 | 2,187 | 116 | 712 | 198 |
01 Apr 23 | 2,297 | 118 | 728 | 206 |
31 Dec 22 | 2,036 | 144 | 641 | 191 |
01 Oct 22 | 1,746 | 171 | 559 | 170 |
02 Jul 22 | 1,505 | 191 | 487 | 153 |
02 Apr 22 | 1,244 | 223 | 408 | 139 |
01 Jan 22 | 1,239 | 230 | 395 | 137 |
02 Oct 21 | 1,207 | 232 | 382 | 136 |
03 Jul 21 | 1,177 | 224 | 371 | 129 |
03 Apr 21 | 1,173 | 229 | 376 | 126 |
02 Jan 21 | 1,144 | 240 | 369 | 119 |
26 Sep 20 | 1,096 | 223 | 361 | 110 |
27 Jun 20 | 1,047 | 222 | 351 | 106 |
28 Mar 20 | 976 | 211 | 330 | 99 |
28 Dec 19 | 938 | 196 | 315 | 93 |
28 Sep 19 | 913 | 190 | 306 | 91 |
29 Jun 19 | 895 | 198 | 297 | 87 |
30 Mar 19 | 877 | 197 | 289 | 83 |
29 Dec 18 | 858 | 194 | 285 | 81 |
29 Sep 18 | 843 | 139 | 290 | 76 |
30 Jun 18 | 826 | 118 | 284 | 71 |
31 Mar 18 | 807 | 119 | 280 | 67 |
30 Dec 17 | 790 | 125 | 273 | 65 |
30 Sep 17 | 766 | 348 | 271 | 60 |
01 Jul 17 | 740 | 340 | 263 | 61 |
01 Apr 17 | 720 | 325 | 260 | 59 |
31 Dec 16 | 713 | 311 | 255 | 58 |
01 Oct 16 | 672 | 109 | 255 | 58 |
02 Jul 16 | 657 | 101 | 257 | 57 |
02 Apr 16 | 640 | 90 | 254 | 55 |
02 Jan 16 | 623 | 83 | 253 | 56 |
03 Oct 15 | 623 | 80 | 244 | 58 |
04 Jul 15 | 613 | 76 | 246 | 58 |
04 Apr 15 | 596 | 70 | 246 | 58 |
03 Jan 15 | 580 | 73 | 241 | 57 |
27 Sep 14 | 556 | 61 | 235 | 55 |
28 Jun 14 | 545 | 61 | 226 | 55 |
29 Mar 14 | 543 | 65 | 219 | 55 |
28 Dec 13 | 541 | 58 | 215 | 56 |
28 Sep 13 | 537 | 64 | 211 | 55 |
29 Jun 13 | 525 | 62 | 206 | 54 |
30 Mar 13 | 510 | 63 | 200 | 51 |
Quality Earnings: MASI has high quality earnings.
Growing Profit Margin: MASI's current net profit margins (4%) are lower than last year (7.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MASI's earnings have declined by 10.9% per year over the past 5 years.
Accelerating Growth: MASI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MASI had negative earnings growth (-43.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (8.7%).
Return on Equity
High ROE: MASI's Return on Equity (6%) is considered low.